Pharmanetics, Inc.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9, 2003
PharmaNetics, Inc.
(Exact name of registrant as
specified in its charter)
North Carolina
(State or other jurisdiction of incorporation)
| 0-25133 |
|
56-2098302 |
| (Commission file Number) |
|
(IRS Employer ID Number) |
| 9401 Globe Center Drive, Morrisville, North Carolina |
|
27560 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area
code 919-582-2600
NA
(Former name or former address, if changed since last report)
Item 5. Other Events.
On January 9, 2003, the Registrant issued the press release filed herewith as Exhibit 99.1.
Item 7. Exhibits
(c) Exhibits
| 99.1 |
|
Press release issued on January 9, 2003. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
|
|
|
PHARMANETICS, INC. |
| |
| Date: January 9, 2003 |
|
|
|
/s/ John P. Funkhouser
|
| |
|
|
|
|
|
John P. Funkhouser President and Chief Executive Officer |